Sign inCreate account

Report workspace

Add to folder
NCT03373981TERMINATEDanonymous

Non-invasive Brain Stimulation for the Treatment of Depression Symptoms in ALS: A Pilot Study

Sponsor

Source record

Hospital for Special Surgery, New York

Phase

Source record

NA

Modality

AI-normalized

medical device

Target

AI-normalized

rTMS

Indication / condition

AI-normalized

ALS

Intervention

Source record

rTMS

Related intelligence directories

Indication directory: ALSModality directory: medical deviceTarget directory: rTMS

Source & freshness

Source record

NCT ID

NCT03373981

Original source

ClinicalTrials.gov

Source last updated

Nov 14, 2022

Ingested at

Jun 18, 2026

Internal sync

Jun 18, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT03373981

Title

Non-invasive Brain Stimulation for the Treatment of Depression Symptoms in ALS: A Pilot Study

Sponsor

Hospital for Special Surgery, New York

Status

TERMINATED

Phase

NA

Condition raw

ALS

Condition normalized

ALS

Modality raw

medical device

Modality normalized

medical device

Target raw

rTMS

Target normalized

rTMS

Interventions

rTMS

Public preview

Source record

This is an open-label clinical trial to determine the safety of rTMS and efficacy in improving depression symptoms, quality of life and cognition deficits among patients with Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative disorders.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Non-invasive Brain Stimulation for the Treatment of Depression Symptoms in ALS: A Pilot Study

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 18, 2026

NCT ID

NCT03373981

Status

TERMINATED

Phase

NA

Sponsor

Hospital for Special Surgery, New York

Executive brief

Investment-Ready Snapshot

This is an open-label clinical trial to determine the safety of rTMS and efficacy in improving depression symptoms, quality of life and cognition deficits among patients with Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative disorders.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedNov 14, 2022
Internal syncJun 18, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT03373981

Indication

ALS

Modality

medical device

Target

rTMS

Intervention

rTMS

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.